Direction to the Independent Hospital Pricing Authority on the performance of its functions under section 226 of the National Health Reform Act 2011 - No. 1/2014

What this is: A formal instruction from the Minister for Health (Peter Dutton) to the Independent Hospital Pricing Authority (IHPA) — the body that sets prices for public hospital services.

What it does:

• Orders the IHPA to work out the costs of running clinical trials in Australian hospitals by 30 June 2015
• Specifically, they must price a "refined list of standard items" (basically a standardised list of medical services and resources used in trials) plus any extra items needed beyond standard hospital care
• Requires the IHPA to report back to the Standing Council on Health after completing this work
• Tells the IHPA what factors to consider when doing this pricing work, including:
  • What each item actually involves (the "actual activity")
  • Cost-recovery principles (making sure the pricing covers actual costs)
  • Input from trial sponsors and private hospitals

Who it affects:

• The IHPA — must do the costing work
• Hospitals running clinical trials — will eventually get clearer pricing for trial-related services
• Clinical trial sponsors (pharmaceutical companies, research bodies) — get a say in the process

Clinical trials are crucial for developing new treatments, but hospitals often struggle to recover the true costs of hosting them. This direction aims to create a transparent, standardised pricing system so hospitals aren't out of pocket, and trials can run more smoothly in Australia.